Name | Number of supported studies | Average coverage | |
---|---|---|---|
transit amplifying cell | 6 studies | 28% ± 7% | |
T cell | 6 studies | 32% ± 5% | |
B cell | 4 studies | 22% ± 3% | |
plasmablast | 4 studies | 33% ± 15% | |
deuterosomal cell | 4 studies | 23% ± 5% | |
abnormal cell | 4 studies | 23% ± 7% | |
pro-B cell | 4 studies | 24% ± 3% | |
erythrocyte | 4 studies | 37% ± 16% | |
natural killer cell | 4 studies | 27% ± 7% | |
CD4-positive, alpha-beta T cell | 4 studies | 37% ± 10% | |
CD8-positive, alpha-beta T cell | 4 studies | 32% ± 9% | |
epithelial cell | 3 studies | 33% ± 10% | |
plasma cell | 3 studies | 27% ± 5% | |
hematopoietic precursor cell | 3 studies | 21% ± 4% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 23% ± 2% | |
effector CD8-positive, alpha-beta T cell | 3 studies | 31% ± 4% |
Insufficient scRNA-seq data for expression of CENPF at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 97% | 3233.72 | 1758 / 1809 | 92% | 38.50 | 436 / 472 |
ovary | 63% | 186.42 | 114 / 180 | 89% | 18.49 | 384 / 430 |
intestine | 58% | 654.06 | 559 / 966 | 91% | 22.17 | 482 / 527 |
lung | 61% | 273.79 | 353 / 578 | 85% | 22.91 | 976 / 1155 |
esophagus | 46% | 845.67 | 660 / 1445 | 99% | 47.66 | 182 / 183 |
breast | 46% | 127.34 | 210 / 459 | 94% | 38.19 | 1048 / 1118 |
stomach | 46% | 404.14 | 166 / 359 | 92% | 24.95 | 263 / 286 |
uterus | 40% | 120.26 | 68 / 170 | 97% | 40.74 | 446 / 459 |
bladder | 19% | 63.48 | 4 / 21 | 89% | 24.04 | 450 / 504 |
tonsil | 0% | 0 | 0 / 0 | 100% | 46.18 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.46 | 1 / 1 |
spleen | 97% | 692.47 | 234 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 73% | 278.12 | 189 / 258 | 19% | 3.31 | 44 / 230 |
lymph node | 0% | 0 | 0 / 0 | 90% | 21.80 | 26 / 29 |
pancreas | 8% | 22.78 | 26 / 328 | 66% | 10.20 | 117 / 178 |
brain | 13% | 33.06 | 339 / 2642 | 47% | 10.76 | 328 / 705 |
liver | 13% | 64.67 | 30 / 226 | 40% | 6.17 | 162 / 406 |
peripheral blood | 53% | 2434.02 | 494 / 929 | 0% | 0 | 0 / 0 |
adipose | 42% | 126.86 | 503 / 1204 | 0% | 0 | 0 / 0 |
prostate | 25% | 75.50 | 62 / 245 | 15% | 1.75 | 74 / 502 |
kidney | 21% | 107.38 | 19 / 89 | 13% | 1.86 | 120 / 901 |
thymus | 16% | 47.87 | 104 / 653 | 15% | 5.31 | 92 / 605 |
eye | 0% | 0 | 0 / 0 | 16% | 1.42 | 13 / 80 |
blood vessel | 14% | 39.45 | 185 / 1335 | 0% | 0 | 0 / 0 |
heart | 10% | 33.37 | 86 / 861 | 0% | 0 | 0 / 0 |
muscle | 2% | 5.22 | 20 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000278 | Biological process | mitotic cell cycle |
GO_0007059 | Biological process | chromosome segregation |
GO_0051310 | Biological process | metaphase chromosome alignment |
GO_0051382 | Biological process | kinetochore assembly |
GO_0001822 | Biological process | kidney development |
GO_0051301 | Biological process | cell division |
GO_0010389 | Biological process | regulation of G2/M transition of mitotic cell cycle |
GO_0021591 | Biological process | ventricular system development |
GO_0071897 | Biological process | DNA biosynthetic process |
GO_0030154 | Biological process | cell differentiation |
GO_0007517 | Biological process | muscle organ development |
GO_0015031 | Biological process | protein transport |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0007094 | Biological process | mitotic spindle assembly checkpoint signaling |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0016202 | Biological process | regulation of striated muscle tissue development |
GO_0000775 | Cellular component | chromosome, centromeric region |
GO_0097539 | Cellular component | ciliary transition fiber |
GO_0030496 | Cellular component | midbody |
GO_0000922 | Cellular component | spindle pole |
GO_0045120 | Cellular component | pronucleus |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005813 | Cellular component | centrosome |
GO_0000776 | Cellular component | kinetochore |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005930 | Cellular component | axoneme |
GO_0016363 | Cellular component | nuclear matrix |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000940 | Cellular component | outer kinetochore |
GO_0036064 | Cellular component | ciliary basal body |
GO_0000785 | Cellular component | chromatin |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005819 | Cellular component | spindle |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0008017 | Molecular function | microtubule binding |
GO_0070840 | Molecular function | dynein complex binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CENPF |
Protein name | Centromere protein F (CENP-F) (AH antigen) (Kinetochore protein CENPF) (Mitosin) Centromere protein F |
Synonyms | |
Description | FUNCTION: Required for kinetochore function and chromosome segregation in mitosis. Required for kinetochore localization of dynein, LIS1, NDE1 and NDEL1. Regulates recycling of the plasma membrane by acting as a link between recycling vesicles and the microtubule network though its association with STX4 and SNAP25. Acts as a potential inhibitor of pocket protein-mediated cellular processes during development by regulating the activity of RB proteins during cell division and proliferation. May play a regulatory or permissive role in the normal embryonic cardiomyocyte cell cycle and in promoting continued mitosis in transformed, abnormally dividing neonatal cardiomyocytes. Interaction with RB directs embryonic stem cells toward a cardiac lineage. Involved in the regulation of DNA synthesis and hence cell cycle progression, via its C-terminus. Has a potential role regulating skeletal myogenesis and in cell differentiation in embryogenesis. Involved in dendritic cell regulation of T-cell immunity against chlamydia. . |
Accessions | ENST00000706765.1 ENST00000366955.8 A0A9L9PXU7 P49454 |